How to Help Your Patients Save Money on Doral (Quazepam): A Provider's Guide to Savings Programs

Quazepam is one of the more expensive sleep medications available in the United States. Without insurance coverage, patients can face bills of $600-$900 or more per 30-tablet supply. For clinicians who prescribe quazepam, understanding the cost landscape and available savings tools is essential to ensuring medication adherence and avoiding the clinical consequences of untreated insomnia.

This guide summarizes the cost situation and practical strategies providers can share with their patients.

Why Quazepam Is So Expensive: The Market Context

Quazepam's high cost is driven by several structural factors:

• Very limited manufacturer competition. With only Atland Pharmaceuticals producing the authorized generic and no other manufacturers actively competing, there is no price competition driving costs down.
• Extremely low prescription volume. Pharmacies and distributors that do carry it purchase in small quantities, driving up per-unit cost.
• No manufacturer patient assistance program. Unlike many brand medications, there is no known manufacturer-sponsored PAP for quazepam.
• Brand discontinuation. The branded Doral has been discontinued, and there is no longer any copay card or brand savings program to reduce cost.

Current Cash Pricing: What Patients Are Paying

Based on 2025-2026 data from major drug pricing services:

• Average retail cash price: ~$813 per 30 tablets (quazepam 15 mg), per SingleCare data
• Best discount card price: ~$655 per 30 tablets with SaveHealth (as of early 2026)
• With insurance: Varies significantly; copay $20-$80+ if covered; prior auth often required

Strategy 1: Recommend Prescription Discount Cards

For patients without coverage, or when their copay exceeds the discount card price, these services can reduce cost significantly:

• SaveHealth (savehealth.com): Lowest known price for quazepam (~$655/30 tablets); free savings card, no enrollment needed
• GoodRx (goodrx.com): Search for "quazepam" (not Doral) — compare across pharmacies. Prices vary by location.
• SingleCare (singlecare.com): Accepted at major pharmacy chains; shows ~$834 at some locations — always compare with GoodRx

Advise patients: discount cards cannot be used with insurance simultaneously. Instruct them to check both prices and use whichever is lower.

Strategy 2: Assist with Insurance Prior Authorization

Because quazepam is a specialty/niche medication, most insurance plans that do cover it require prior authorization (PA). As the prescribing provider, your office's PA support is critical. Key documentation elements for a quazepam PA:

• Diagnosis: Chronic insomnia disorder (ICD-10: G47.00) or other insomnia-related code
• Step therapy documentation: Prior failure of at least 2 other sleep medications (e.g., zolpidem, eszopiclone, temazepam) with documented adverse effects or insufficient response
• Clinical rationale: Why quazepam specifically — note its efficacy for both sleep onset and maintenance, its minimal rebound insomnia profile, and its selectivity for type 1 receptors
• Duration of therapy: Expected treatment course and monitoring plan

Strategy 3: Tablet Splitting for Dose Optimization and Cost Reduction

Quazepam 15 mg tablets are functionally scored, meaning they can be split to achieve 7.5 mg doses. For patients who respond adequately to 7.5 mg — which is clinically supported, particularly in elderly patients — prescribing 15 mg scored tablets with instructions to take half effectively doubles the supply duration and halves the cost.

This is a standard and accepted clinical approach. Ensure patients have an inexpensive pill splitter and understand how to split the tablet correctly.

Strategy 4: Medicare Part D and Medicaid Guidance

Medicare Part D coverage of quazepam is variable. Benzodiazepines became fully Part D-covered in 2013, so quazepam is theoretically coverable. However, many Part D plans do not include it on their formulary due to its extremely low utilization.

For Medicare patients:

• Check the patient's specific Part D plan formulary before prescribing
• If not covered, submit a formulary exception request with clinical documentation
• For uncovered patients, a GoodRx or SaveHealth coupon may be more cost-effective than fighting with the formulary

Strategy 5: When Cost Is the Primary Barrier, Consider Alternatives

If cost and access barriers make quazepam impractical for a patient, the following alternatives are both clinically reasonable and dramatically cheaper:

• Temazepam 15-30 mg: ~$15-$40/30 tablets; benzodiazepine; treats onset and maintenance
• Zolpidem 5-10 mg: ~$10-$25/30 tablets with GoodRx; best for sleep onset
• Eszopiclone 1-3 mg: ~$25-$60/30 tablets; treats onset and maintenance
• Doxepin 3-6 mg: ~$30-$80/30 tablets; non-controlled; FDA-approved for sleep maintenance; particularly useful in elderly patients or those with anxious depression

Helping Patients Find Quazepam When Cost AND Access Are Issues

For patients who want to remain on quazepam and need both an affordable price and a pharmacy that stocks it, medfinder for providers can help identify pharmacies near the patient that can fill the prescription. This saves patients significant time and helps ensure medication continuity.

Provider Quick Reference: Quazepam Savings Strategies

• Best discount card: SaveHealth.com (~$655/30 tablets) or GoodRx.com (varies by pharmacy)
• Tablet splitting: 15 mg tablets are scored; 7.5 mg dose is clinically effective — doubles supply
• PA support: Document step therapy failures (zolpidem, eszopiclone) and clinical rationale in the PA request
• No manufacturer PAP: As of 2026, no known manufacturer patient assistance program exists for quazepam
• Access support: medfinder.com/providers helps patients find local pharmacies that carry quazepam
• Mail-order: Sterling Specialty Pharmacy, 888-618-4126; e-scribe #2433693